Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
Monika Sparber‐Sauer, Daniel Orbach, Fariba Navid, Simone Hettmer, Stephen X. Skapek, Nadège Corradini, Michela Casanova, Aaron R. Weiss, Matthias Schwab, Andrea Ferrari
Topics & Concepts
MedicineSorafenibPazopanibImatinibFibromatosisAggressive fibromatosisOncologyTyrosine kinaseClinical trialInternal medicinePharmacologySurgerySunitinibCancerMyeloid leukemiaHepatocellular carcinomaReceptorSoft tissue tumor case studiesSarcoma Diagnosis and TreatmentNeurofibromatosis and Schwannoma Cases